Name | Number of supported studies | Average coverage | |
---|---|---|---|
dendritic cell | 5 studies | 27% ± 9% | |
ciliated cell | 3 studies | 23% ± 6% |
Insufficient scRNA-seq data for expression of LY75 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 2282.34 | 652 / 653 | 97% | 17.95 | 587 / 605 |
lung | 99% | 1272.07 | 574 / 578 | 82% | 5.57 | 949 / 1155 |
stomach | 82% | 476.27 | 293 / 359 | 95% | 11.72 | 272 / 286 |
bladder | 90% | 666.57 | 19 / 21 | 86% | 8.09 | 433 / 504 |
breast | 98% | 1365.66 | 451 / 459 | 71% | 4.07 | 791 / 1118 |
intestine | 69% | 1339.42 | 671 / 966 | 96% | 12.59 | 506 / 527 |
uterus | 77% | 343.46 | 131 / 170 | 80% | 6.77 | 366 / 459 |
kidney | 89% | 469.20 | 79 / 89 | 58% | 3.15 | 525 / 901 |
esophagus | 60% | 377.81 | 864 / 1445 | 81% | 8.69 | 148 / 183 |
ovary | 49% | 160.21 | 89 / 180 | 87% | 5.33 | 373 / 430 |
pancreas | 42% | 141.68 | 139 / 328 | 93% | 10.05 | 165 / 178 |
skin | 90% | 1121.79 | 1620 / 1809 | 26% | 1.27 | 124 / 472 |
lymph node | 0% | 0 | 0 / 0 | 100% | 25.86 | 29 / 29 |
spleen | 100% | 2202.33 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.13 | 1 / 1 |
blood vessel | 98% | 1104.58 | 1311 / 1335 | 0% | 0 | 0 / 0 |
adipose | 98% | 694.34 | 1177 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 76% | 274.17 | 197 / 258 | 20% | 1.17 | 45 / 230 |
peripheral blood | 95% | 5980.28 | 884 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 9.54 | 42 / 45 |
prostate | 76% | 357.59 | 186 / 245 | 9% | 0.28 | 45 / 502 |
brain | 36% | 123.44 | 948 / 2642 | 15% | 0.48 | 106 / 705 |
heart | 31% | 105.41 | 264 / 861 | 0% | 0 | 0 / 0 |
liver | 5% | 13.02 | 12 / 226 | 8% | 0.36 | 32 / 406 |
muscle | 3% | 7.57 | 21 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 3% | 0.16 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006955 | Biological process | immune response |
GO_0006954 | Biological process | inflammatory response |
GO_0006897 | Biological process | endocytosis |
GO_0070062 | Cellular component | extracellular exosome |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0038023 | Molecular function | signaling receptor activity |
GO_0030246 | Molecular function | carbohydrate binding |
Gene name | LY75 |
Protein name | Alternative protein LY75 Lymphocyte antigen 75 (Ly-75) (C-type lectin domain family 13 member B) (DEC-205) (gp200-MR6) (CD antigen CD205) |
Synonyms | CD205 CLEC13B |
Description | FUNCTION: Acts as an endocytic receptor to direct captured antigens from the extracellular space to a specialized antigen-processing compartment (By similarity). Causes reduced proliferation of B-lymphocytes. . |
Accessions | O60449 L8E7D1 ENST00000263636.5 [O60449-1] |